LDHA inhibition can significantly restore the sensitivity of chemotherapy drugs: LDHA knockdown sensitizes oral squamous cell carcinoma cells (122) and breast cancer cells (140) to Taxol and lung cancer cells to low doses of paclitaxel (141) via siRNA/shRNA. The gene discussed is LDHA; the disease is squamous cell carcinoma.